Skip to main content
GENFIT logo

GENFIT — Investor Relations & Filings

Ticker · GNFT ISIN · FR0004163111 LEI · 969500XPWN2DMZQA5X73 PA Professional, scientific and technical activities
Open in API
Filings indexed 681 across all filing types
Latest filing 2022-04-20 AGM Information
Country FR France
Listing PA GNFT

About GENFIT

https://www.genfit.com

GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.

Recent filings

Filing Released Lang Actions
GENFIT Annual Combined General Meeting of May 25, 2022 — Availability of Preparatory Documents
AGM Information Classification · 98% confidence The document is explicitly titled "PRESS RELEASE" and announces the availability of preparatory documents for the "GENFIT Annual Combined General Meeting of May 25, 2022". It details where the documentation is available (website, legal bulletin) and mentions the process for shareholders to vote online. This content is focused on convening a shareholder meeting and providing the necessary materials for that meeting, which aligns perfectly with the definition of AGM Information (AGM-R). While it announces the meeting, the core subject is the AGM itself and the associated materials, making AGM-R more specific than a general Report Publication Announcement (RPA).
2022-04-20 English
GENFIT Reports Full-Year 2021 Financial Results and Provides Corporate Update
Earnings Release Classification · 99% confidence The document is titled "GENFIT Reports Full-Year 2021 Financial Results and Provides Corporate Update." It contains detailed consolidated financial statements for the year ended December 31, 2021, including revenues, expenses, operating income/loss, and net profit/loss, along with management commentary on the financial performance and business highlights for the full year. This content structure is characteristic of an Annual Report or a comprehensive report covering a full fiscal year. Although it mentions that the financial statements are *unaudited* and audit procedures are underway, the primary purpose and content delivery align with the comprehensive annual reporting requirement, which is best classified as a 10-K (Annual Report) in the context of US-style filings, or a comprehensive annual financial disclosure. Given the detailed financial tables covering the entire year, it is more than just an Earnings Release (ER) or Interim Report (IR). Since it covers the full year's performance, 10-K is the most appropriate classification, even if it might be a non-US equivalent filing that serves the same function. FY 2021
2022-04-07 English
GENFIT : Résultats financiers annuels 2021 et point sur les activités de la Société
Earnings Release Classification · 95% confidence The document is an 'Earnings Release' (ER) for the fiscal year 2021. It contains key financial highlights, a summary of consolidated accounts, management commentary on business performance, and future outlooks. It is not a full Annual Report (10-K) as it is a summary document (approx. 42k characters) and explicitly states that audit procedures are still in progress. It follows the standard format for a periodic earnings announcement. FY 2021
2022-04-07 French
GENFIT Annonce un Chiffre d’Affaires et une Position de Trésorerie robustes au 31 décembre 2021
Earnings Release Classification · 99% confidence The document is a press release dated February 28, 2022, announcing the company's 'Chiffre d'Affaires' (Revenue) and 'Position de Trésorerie' (Cash Position) as of December 31, 2021. It highlights key financial figures for the year 2021 and provides updates on clinical trials and future reporting dates. This format, focusing on preliminary or key financial highlights for a period (in this case, the full year 2021), aligns perfectly with the definition of an Earnings Release (ER). Although it mentions that the full annual results and the Universal Registration Document (which contains the 10-K equivalent information) will be published later (April 2022), this specific document serves as the initial announcement of the results. FY 2021
2022-02-28 French
GENFIT Announces Solid Revenues and Cash Position as of December 31, 2021
Earnings Release Classification · 98% confidence The document is titled "GENFIT Announces Solid Revenues and Cash Position as of December 31, 2021" and provides unaudited financial information (cash position, revenues) for the year ended December 31, 2021. It discusses key financial metrics and operational updates (like the Ipsen licensing deal and COVID impact on trials). This content structure strongly indicates an announcement of periodic financial results, which aligns with the Earnings Release (ER) definition, which covers initial announcements of periodical financial results (key highlights only). Although it mentions future reports (Full-year 2021 results on April 7, 2022, and 20-F by end of April 2022), the current document itself is the announcement of the year-end cash position and revenues, making ER the most appropriate classification for this summary release. FY 2021
2022-02-28 English
GENFIT: 2022 Financial Calendar
Report Publication Announcement Classification · 99% confidence The document is explicitly titled '# **PRESS RELEASE**' and its primary content is announcing the '2022 Financial Calendar' for the company GENFIT. It lists future dates for publishing financial results (revenue, cash position, full-year statements, half-year statements) and the date for the Annual Shareholders Meeting. This document is not the financial report itself (like 10-K or IR), nor is it the actual AGM materials or the results of a vote. It is an announcement about the schedule of future corporate events and filings. Since it is a general announcement regarding the timing and publication of future reports, it best fits the 'Report Publication Announcement' (RPA) category, which covers announcements about the timing or release of company reports. It is not a general regulatory filing (RNS) because RPA is more specific for scheduling announcements.
2022-01-24 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.